Buy or sell Emulate stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

Emulate Stock

Organs-on-Chips Company

Founded

2013

Notable Investors

Glass Wall Syndicate

Headquarters

Boston MA, US

Total Funding

$143M

About Emulate Stock

Emulate, Inc. is a private company focused on commercializing Organs-on-Chips as an automated human bioemulation platform that achieves a new standard for mimicking true human physiology so that responses to medicines, chemicals and diseases can be accurately predicted. Through co-innovation with collaborators and internal programs, Emulate is advancing product innovation, design and safety across a range of applications in drug development, personalized medicine, agriculture and chemical-based consumer products.

Investors

Funding History

July 2014$12.0M
March 2016$45.0M
June 2018$36.0M
August 2019$50.0M

Management

Chief Executive Officer

Jim Corbett

Chief Technology Officer

Daniel Levner

Press

Other Companies

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Emulate or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Join 200K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo